Back

Clinical safety and efficacy of tolvaptan for acute phase therapy in patients with low-flow severe aortic stenosis

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Acute heart failure 2 Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Miho Mitsui

Teikyo University, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
PIONEER-HF criteria ready for the prime time? Data from REDINSCOR II registry
Doctor R. Vidal-Perez (A Coruna, ES)
Abstract Slides
Presentation thumbnail
Use of intravenous vasodilators in patients hospitalized with acute heart failure: insights from Tokyo cardiovascular care unit network database
Doctor Y. Shiraishi (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Measurement of liver fibrosis marker : type IV collagen 7S among patients with acute heart failure and its relationship with the Enhanced Liver Fibrosis (ELF) score
Mr K. Aida (Osaka, JP)
Abstract Slides
Presentation thumbnail
Association between renal dysfunction and cardiac sympathetic innervation in patients with heart failure
Doctor F. Marsico (Naples, IT)
Abstract Slides
Presentation thumbnail
Pathophysiology of diaphragm involvement in systolic heart failure: insights from diaphragm ultrasound and phrenic nerve stimulation studies
Doctor J. Spiesshoefer (Pisa, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Acute heart failure 2

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Presentation
Early hospital management
thumbnail
Congress Presentation
Tips and tricks in combining diuretics

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources